Clinical Trial Update: Immune Response in Patients Who Have Undergone Vaccine Therapy for Stage III or Stage IV Breast Cancer That Overexpresses HER2 [NA]

View source ↗

Summary

This completed clinical trial evaluated the immune response to a vaccine therapy in patients with stage III or stage IV breast cancer that overexpresses HER2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Washington | Conditions: Breast Cancer | NA | Status: COMPLETED